Molecular Detection of Diffusely Adherent Escherichia coli Strains Associated with Diarrhea in Shiraz, Iran

Abbasi, Parvin; Kargar, Mohammad; Doosti, Abbas; Mardaneh, Jalal; Ghorbani-Dalini, Sadegh

doi:10.5812/pedinfect.37629

Cited by 11 publications

(4 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DAEC was found more often in isolates from diarrheic isolates (29/35; 82.8%) as compared to isolates from UTI isolates (6/35; 17.1%). The prevalence of DAEC ranged from about 8% (Shiraz)[ 27 ] to 9% (Tehran and Sanandaj)[ 16 ] in Iran [ Appendix 1 and Figure 3 ].…”

Section: Resultsmentioning

confidence: 99%

An overview of diarrheagenic Escherichia coli in Iran: A systematic review and meta-analysis

et al. 2019

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

An overview of diarrheagenic Escherichia coli in Iran: A systematic review and meta-analysis

et al. 2019

View full text Add to dashboard Cite

“…Pathogenic E. coli is divided into two subgroups according to its predilection, namely, diarrheagenic E. coli (DEC) [54,58], which is pathogenic in the digestive tract, and ExPEC [26,59], which causes systemic infections [50]. Diarrheagenic E. coli is found in the intestinal tracts of both humans and animals and is classified into eight sub-pathotypes, including EPEC [60,61], enterotoxigenic E. coli (ETEC) [62][63][64], enterohemorrhagic E. coli (EHEC) [65][66][67], enteroinvasive E. coli (EIEC) [68][69][70][71], diffusely adherent E. coli [72][73][74][75][76], enteroaggregative E. coli (EAEC) [75,[77][78][79][80][81], adherent invasive E. coli [82][83][84][85], and Stx-producing EAEC [65,77,81,86]. Diarrheagenic E. coli is transmitted through food or water contaminated with animal or human feces and causes gastroenteritis and diarrhea.…”

Section: Avian Pathogenic E Colimentioning

confidence: 99%

Occurrence, antimicrobial resistance, and potential zoonosis risk of avian pathogenic Escherichia coli in Indonesia: A review

2022

View full text Add to dashboard Cite

Avian pathogenic Escherichia coli (APEC) causes avian colibacillosis or colibacillosis and is a major endemic disease of poultry worldwide, including in Indonesia. It is characterized by a black proventriculus and can damage other organs, leading to pericarditis, perihepatitis, water sacculitis, mesenteritis, and omphalitis. The APEC strain is one of the six main sub-pathotypes of the extraintestinal pathogenic E. coli (ExPEC) pathotype. The relationship between APEC and infection in humans is questionable. The previous studies have suggested poultry products, including meat and eggs, as a potential source of infection for the transmission of ExPEC disease to humans. Due to the absence of reporting of disease incidents and the lack of literature updates on this disease, it seems as if APEC does not exist in Indonesia. Since bacterial resistance is a growing problem in Indonesia, and globally, the World Health Organization issued a statement regarding the importance of assessing related factors and their control strategies. Antimicrobial resistance, especially multidrug resistance, presents a challenge when treating infectious diseases. In Indonesia, the incidence of resistance to several antimicrobials in cases of avian colibacillosis is high. In addition, avian and human extraintestinal E. coli infections present a potential zoonotic risk. Furthermore, a relationship exists between antibiotic resistance to foodborne bacteria and the occurrence of antibiotic resistance in humans, so the use of antibiotics in the poultry industry must be controlled. Therefore, the One Health strategy should be implemented to prevent the overuse or misuse of antibiotics in the poultry industry. This review aimed to increase awareness of people who are at risk of getting Avian pathogenic Escherichia coli (APEC) from poultry by controlling the spread of APEC by maintaining a clean environment and hygienic personnel in poultry farms.

show abstract

“…LVX resistance in E. coli isolates from patients with diarrhea is surprisingly low. For instance, it was 0% and 5.6% in non-ESBL- and ESBL-producing isolates, respectively ( 51 – 53 ). Two studies used more than one organ specimen (specimens from different body sites), and the rate of resistance to LVX was 43.8% and 61.6% in the hospitalized patients ( Fig.…”

Section: Introductionmentioning

confidence: 99%

“…However, LVX resistance was different in various geographic regions of Iran. The antimicrobial resistance of E. coli to LVX was higher in the western provinces of Iran, such as Lorestan ( 46 ), Qazvin, Zanjan ( 47 ), and Kermanshah ( 44 ) than in the central ones, such as Tehran, Alborz, and Semnan ( 54 , 55 ), as well as in the southern province of Fars ( 51 , 52 ). According to the study conducted in Yasuj, the center of Kohgiluyeh and Boyer-Ahmad Province, 50 (34.7%) of 144 urine samples showed E. coli resistance to LVX ( 56 ).…”

Section: Introductionmentioning

confidence: 99%

Resistance pattern of Escherichia coli to levofloxacin in Iran, a narrative review

Hassanshahi¹,

Darehkordi²,

Fathollahi³

et al. 2020

IJM

View full text Add to dashboard Cite

Fluoroquinolones (FQs) are widely used in the treatment of infections caused by Escherichia coli. FQs are broad spectrum antibiotics with high tissue penetration, and ease of use. Therefore, given the concerns existing about drug resistance, we aim to review the latest findings about resistance patterns to levofloxacin (LVX) along with other FQs in E. coli infections in different parts of Iran. Evidence shows that quinolones have been used in Iran for nearly 50 years, and that 0-65% of E. coli isolates show resistance to FQs. In the western parts of Iran, the highest rate of resistance to LVX (66.7%) has been reported among patients having urinary tract infections with E. coli isolates. Few studies and information exist on the antimicrobial re- sistance of E. coli to LVX in different geographical locations of Iran. However, the findings of various studies on this subject show that E. coli resistance to LVX is more in the western part of Iran than in central and southern regions, but it is similar among inpatients and outpatients. Therefore, it is reasonable advisable to limit the overuse, inappropriate prescription, and self-medication of LVX to prevent the induction of FQ-resistant strains. Accordingly, in order to obtain a clearer image of resistance to FQs, especially LVX in E. coli in Iran, more extensive investigations in different geographical locations and periods of time are required. In addition, antimicrobial stewardship would be helpful in this regard.

show abstract

Molecular Detection of Diffusely Adherent Escherichia coli Strains Associated with Diarrhea in Shiraz, Iran

Cited by 11 publications

References 30 publications

An overview of diarrheagenic Escherichia coli in Iran: A systematic review and meta-analysis

An overview of diarrheagenic Escherichia coli in Iran: A systematic review and meta-analysis

Occurrence, antimicrobial resistance, and potential zoonosis risk of avian pathogenic Escherichia coli in Indonesia: A review

Resistance pattern of Escherichia coli to levofloxacin in Iran, a narrative review

Contact Info

Product

Resources

About